Napa Parinyanitikul - Concepedia

Author

Napa Parinyanitikul

Chulalongkorn University ORCID

Also Known As

N Parinyanitikul, N. Parinyanitikul, Napa Parinyanitikul, T. Dejthevaporn

102

Publications

594

Citations

H-Index

Concepts

All Affiliations

Chulalongkorn University King Chulalongkorn Memorial Hospital The University of Texas MD Anderson Cancer Center Seoul National University Hospital National Cancer Centre Singapore

About

Napa Parinyanitikul is an author at Chulalongkorn University specializing in oncology, breast cancer, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	113
2	Engineering	1	1	15
3	Allergy	1	1	18
4	Biomedical Engineering	1	1	15
5	Biomolecular Engineering	1	1	15

Napa Parinyanitikul

Publications

459

Citations

H-Index

Page 1

	Year	Citations
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim, Journal of Clinical Oncology	2024	65
cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer Joohyuk Sohn, Shuying Liu, Napa Parinyanitikul, Journal of Cancer	2014	56
Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer Napa Parinyanitikul, George R. Blumenschein, Yun Wu, Clinical Breast Cancer Survival OutcomesBreast OncologyMedicinePathologyMesothelin Expression	2013	49
Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes Napa Parinyanitikul, Xiudong Lei, Mariana Chávez‐MacGregor, Clinical Breast Cancer Surgical OncologySurvival OutcomesBreast OncologyMedicineBreast Cancer	2014	46
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer Seock‐Ah Im, Alessandra Gennari, Y.H. Park, ESMO Open	2023	43
Functional consequence of the<i>MET-T</i>1010I polymorphism in breast cancer Shuying Liu, Funda Meric‐Bernstam, Napa Parinyanitikul, Oncotarget	2014	42
Cooperative Effect of Oncogenic <i>MET</i> and <i>PIK3CA</i> in an HGF-Dominant Environment in Breast Cancer Shuying Liu, Shunqiang Li, Bailiang Wang, Molecular Cancer Therapeutics	2019	28
Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene Suvimol Niyomnaitham, Napa Parinyanitikul, Ekkapong Roothumnong, PeerJ	2019	28
A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes Tanchanok Ratanajarusiri, Virote Sriuranpong, Piyada Sitthideatphaiboon, Chemotherapy	2016	22
Incidence of infusion hypersensitivity reaction after withholding dexamethasone premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity reaction for weekly paclitaxel chemotherapy Napa Parinyanitikul, Walailuk Tanpipattanakul, Nattaya Poovorawan, Supportive Care in Cancer Breast OncologyAllergyWeekly Paclitaxel ChemotherapyMedicineBreast Cancer	2018	18

Page 1